Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study

Autor: Jovanovic, J.V., Ivey, A., Vannucchi, A.M., Lippert, E., Leibundgut, E. Oppliger, Cassinat, B., Pallisgaard, N., Maroc, N., Hermouet, S., Nickless, G., Guglielmelli, P., Reijden, B.A. van der, Jansen, J.H., Alpermann, T., Schnittger, S., Bench, A., Tobal, K., Wilkins, B., Cuthill, K., McLornan, D., Yeoman, K., Akiki, S., Bryon, J., Jeffries, S., Jones, A., Percy, M.J., Schwemmers, S., Gruender, A., Kelley, T.W., Reading, S., Pancrazzi, A., McMullin, M.F., Pahl, H.L., Cross, N.C., Harrison, C.N., Prchal, J.T., Chomienne, C., Kiladjian, J.J., Barbui, T., Grimwade, D.

Publikováno v: Jovanovic, J V; Ivey, A; Vannucchi, A M; Lippert, E; Oppliger Leibundgut, Elisabeth; Cassinat, B; Pallisgaard, N; Maroc, N; Hermouet, S; Nickless, G; Guglielmelli, P; van der Reijden, B A; Jansen, J H; Alpermann, T; Schnittger, S; Bench, A; Tobal, K; Wilkins, B; Cuthill, K; McLornan, D; ... (2013). Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study. Leukemia, 27(10), pp. 2032-2039. Nature Publishing Group 10.1038/leu.2013.219
Leukemia
Leukemia, 27, 2032-9
Leukemia, 27, 10, pp. 2032-9

Item does not contain fulltext Reliable detection of JAK2-V617F is critical for accurate diagnosis of myeloproliferative neoplasms (MPNs); in addition, sensitive mutation-specific assays can be applied to monitor disease response. However, there has

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8db0b9a0e0a05667e1f59be8f8b90e3d
https://doi.org/10.1038/leu.2013.219

RT-PCR method with increased sensitivity shows persistence of PML-RARA fusion transcripts in patients in long-term remission of APL.

Autor: Tobal, K, Yin, JA Liu, Liu Yin, J A (AUTHOR)

Publikováno v: Leukemia (08876924). Sep98, Vol. 12 Issue 9, p1349-1354. 6p.

New monoallelic (partial tandem duplication) mutation of HNF1a gene in steatotic hepatocellular adenoma

Autor: Sakellariou, S. Morgan, Y. Heaton, N. Portmann, B. Quaglia, A. Tobal, K.

Hepatocellular adenomas (HCAs) containing inactivating HNF1a mutations correspond to a homogenous group of tumors with marked steatosis and no cytological abnormalities or inflammatory infiltrates. We report a case of a 60-year-old woman who was refe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::4c50a1e7c291ca8c48aa535cb670a1e5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3129521

Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction

Autor: Tobal K, Ls, Sherman, Alexander Foss, Sl, Lightman

Publikováno v: Europe PubMed Central

Uveal melanoma is the most common intraocular malignancy in adults and can cause loss of vision in the affected eye and death from metastasis, usually to the liver. The techniques currently used to detect cellular dissemination from the tumor are ina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::16480b07d59f5bb13a4619212524ea97
https://pubmed.ncbi.nlm.nih.gov/8344785

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.